ウェアラブルインジェクターのグローバル市場予測2023-2029

◆英語タイトル:Global Wearable Injectors Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23MY3906)◆商品コード:LP23MY3906
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年5月
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「ウェアラブルインジェクターのグローバル市場」は、過去の販売実績から2022年の世界のウェアラブルインジェクターの総販売量を検討し、2023年から2029年の予測されるウェアラブルインジェクターの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のウェアラブルインジェクターの市場規模を掲載し、XXX百万米ドル規模の世界のウェアラブルインジェクター市場の詳細な分析を提供します。本インサイトレポートは、世界のウェアラブルインジェクター業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のウェアラブルインジェクター市場における各社の独自のポジションをより深く理解するために、ウェアラブルインジェクター製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のウェアラブルインジェクター市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ウェアラブルインジェクターの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。ウェアラブルインジェクターの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ウェアラブルインジェクターのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ウェアラブルインジェクターの世界主要メーカーとしては、Becton、 Dickinson and Company、 Medtronic、 Johnson & Johnson、 Insulet Corporation、 Unilife Corporation、 Enable Injections、 SteadyMed、 Ypsomed Group、 West Pharmaceutical Services、 Unilife、 CeQur、 Sensile Medical、 BD Medical、 Roche、 ScPharmaceuticals、 SteadyMed、 J & Jなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のウェアラブルインジェクター市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査ではウェアラブルインジェクター市場をセグメンテーションし、種類別 (電子式インジェクター、機械式インジェクター、その他)、用途別 (がん、感染症、自己免疫疾患、心血管疾患、血液疾患、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:電子式インジェクター、機械式インジェクター、その他

・用途別区分:がん、感染症、自己免疫疾患、心血管疾患、血液疾患、その他

・地域別区分
南北アメリカ(米国、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のウェアラブルインジェクター市場の10年間の市場状況・展望は?
・世界および地域別に見たウェアラブルインジェクター市場成長の要因は何か?
・ウェアラブルインジェクターの市場機会はエンドマーケットの規模によってどのように変化するのか?
・ウェアラブルインジェクターのタイプ別、用途別の内訳は?
・新型コロナウイルスとロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:ウェアラブルインジェクターの年間販売量2018-2029、地域別現状・将来分析
・ウェアラブルインジェクターの種類別セグメント:電子式インジェクター、機械式インジェクター、その他
・ウェアラブルインジェクターの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・ウェアラブルインジェクターの用途別セグメント:がん、感染症、自己免疫疾患、心血管疾患、血液疾患、その他
・ウェアラブルインジェクターの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のウェアラブルインジェクター市場
・企業別のグローバルウェアラブルインジェクター市場データ:2018-2023年の年間販売量、市場シェア
・企業別のウェアラブルインジェクターの年間売上:2018-2023年の売上、市場シェア
・企業別のウェアラブルインジェクター販売価格
・主要企業のウェアラブルインジェクター生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ウェアラブルインジェクターの地域別レビュー
・地域別のウェアラブルインジェクター市場規模2018-2023:年間販売量、売上
・主要国別のウェアラブルインジェクター市場規模2018-2023:年間販売量、売上
・南北アメリカのウェアラブルインジェクター販売の成長
・アジア太平洋のウェアラブルインジェクター販売の成長
・ヨーロッパのウェアラブルインジェクター販売の成長
・中東・アフリカのウェアラブルインジェクター販売の成長

南北アメリカ市場
・南北アメリカの国別のウェアラブルインジェクター販売量、売上(2018-2023)
・南北アメリカのウェアラブルインジェクターの種類別販売量
・南北アメリカのウェアラブルインジェクターの用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のウェアラブルインジェクター販売量、売上(2018-2023)
・アジア太平洋のウェアラブルインジェクターの種類別販売量
・アジア太平洋のウェアラブルインジェクターの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のウェアラブルインジェクター販売量、売上(2018-2023)
・ヨーロッパのウェアラブルインジェクターの種類別販売量
・ヨーロッパのウェアラブルインジェクターの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のウェアラブルインジェクター販売量、売上(2018-2023)
・中東・アフリカのウェアラブルインジェクターの種類別販売量
・中東・アフリカのウェアラブルインジェクターの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ウェアラブルインジェクターの製造コスト構造分析
・ウェアラブルインジェクターの製造プロセス分析
・ウェアラブルインジェクターの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・ウェアラブルインジェクターの主要なグローバル販売業者
・ウェアラブルインジェクターの主要なグローバル顧客

地域別のウェアラブルインジェクター市場予測レビュー
・地域別のウェアラブルインジェクター市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ウェアラブルインジェクターの種類別市場規模予測
・ウェアラブルインジェクターの用途別市場規模予測

主要企業分析
Becton、 Dickinson and Company、 Medtronic、 Johnson & Johnson、 Insulet Corporation、 Unilife Corporation、 Enable Injections、 SteadyMed、 Ypsomed Group、 West Pharmaceutical Services、 Unilife、 CeQur、 Sensile Medical、 BD Medical、 Roche、 ScPharmaceuticals、 SteadyMed、 J & J
・企業情報
・ウェアラブルインジェクター製品
・ウェアラブルインジェクター販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Wearable Injectors Industry Forecast” looks at past sales and reviews total world Wearable Injectors sales in 2022, providing a comprehensive analysis by region and market sector of projected Wearable Injectors sales for 2023 through 2029. With Wearable Injectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Wearable Injectors industry.
This Insight Report provides a comprehensive analysis of the global Wearable Injectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Wearable Injectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Wearable Injectors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Wearable Injectors and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Wearable Injectors.
The global Wearable Injectors market size is projected to grow from US$ 2873 million in 2022 to US$ 4821.5 million in 2029; it is expected to grow at a CAGR of 4821.5 from 2023 to 2029.
United States market for Wearable Injectors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Wearable Injectors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Wearable Injectors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Wearable Injectors players cover Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed and Ypsomed Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Wearable Injectors market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Electronical Injectors
Mechanical Injectors
Others
Segmentation by application
Cancer
Infectious Disease
Autoimmune Disorder
Cardiovascular Disease
Blood Disorder
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Becton
Dickinson and Company
Medtronic
Johnson & Johnson
Insulet Corporation
Unilife Corporation
Enable Injections
SteadyMed
Ypsomed Group
West Pharmaceutical Services
Unilife
CeQur
Sensile Medical
BD Medical
Roche
ScPharmaceuticals
SteadyMed
J & J
Key Questions Addressed in this Report
What is the 10-year outlook for the global Wearable Injectors market?
What factors are driving Wearable Injectors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Wearable Injectors market opportunities vary by end market size?
How does Wearable Injectors break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Wearable Injectors Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Wearable Injectors by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Wearable Injectors by Country/Region, 2018, 2022 & 2029
2.2 Wearable Injectors Segment by Type
2.2.1 Electronical Injectors
2.2.2 Mechanical Injectors
2.2.3 Others
2.3 Wearable Injectors Sales by Type
2.3.1 Global Wearable Injectors Sales Market Share by Type (2018-2023)
2.3.2 Global Wearable Injectors Revenue and Market Share by Type (2018-2023)
2.3.3 Global Wearable Injectors Sale Price by Type (2018-2023)
2.4 Wearable Injectors Segment by Application
2.4.1 Cancer
2.4.2 Infectious Disease
2.4.3 Autoimmune Disorder
2.4.4 Cardiovascular Disease
2.4.5 Blood Disorder
2.4.6 Others
2.5 Wearable Injectors Sales by Application
2.5.1 Global Wearable Injectors Sale Market Share by Application (2018-2023)
2.5.2 Global Wearable Injectors Revenue and Market Share by Application (2018-2023)
2.5.3 Global Wearable Injectors Sale Price by Application (2018-2023)
3 Global Wearable Injectors by Company
3.1 Global Wearable Injectors Breakdown Data by Company
3.1.1 Global Wearable Injectors Annual Sales by Company (2018-2023)
3.1.2 Global Wearable Injectors Sales Market Share by Company (2018-2023)
3.2 Global Wearable Injectors Annual Revenue by Company (2018-2023)
3.2.1 Global Wearable Injectors Revenue by Company (2018-2023)
3.2.2 Global Wearable Injectors Revenue Market Share by Company (2018-2023)
3.3 Global Wearable Injectors Sale Price by Company
3.4 Key Manufacturers Wearable Injectors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Wearable Injectors Product Location Distribution
3.4.2 Players Wearable Injectors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Wearable Injectors by Geographic Region
4.1 World Historic Wearable Injectors Market Size by Geographic Region (2018-2023)
4.1.1 Global Wearable Injectors Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Wearable Injectors Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Wearable Injectors Market Size by Country/Region (2018-2023)
4.2.1 Global Wearable Injectors Annual Sales by Country/Region (2018-2023)
4.2.2 Global Wearable Injectors Annual Revenue by Country/Region (2018-2023)
4.3 Americas Wearable Injectors Sales Growth
4.4 APAC Wearable Injectors Sales Growth
4.5 Europe Wearable Injectors Sales Growth
4.6 Middle East & Africa Wearable Injectors Sales Growth
5 Americas
5.1 Americas Wearable Injectors Sales by Country
5.1.1 Americas Wearable Injectors Sales by Country (2018-2023)
5.1.2 Americas Wearable Injectors Revenue by Country (2018-2023)
5.2 Americas Wearable Injectors Sales by Type
5.3 Americas Wearable Injectors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Wearable Injectors Sales by Region
6.1.1 APAC Wearable Injectors Sales by Region (2018-2023)
6.1.2 APAC Wearable Injectors Revenue by Region (2018-2023)
6.2 APAC Wearable Injectors Sales by Type
6.3 APAC Wearable Injectors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Wearable Injectors by Country
7.1.1 Europe Wearable Injectors Sales by Country (2018-2023)
7.1.2 Europe Wearable Injectors Revenue by Country (2018-2023)
7.2 Europe Wearable Injectors Sales by Type
7.3 Europe Wearable Injectors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Wearable Injectors by Country
8.1.1 Middle East & Africa Wearable Injectors Sales by Country (2018-2023)
8.1.2 Middle East & Africa Wearable Injectors Revenue by Country (2018-2023)
8.2 Middle East & Africa Wearable Injectors Sales by Type
8.3 Middle East & Africa Wearable Injectors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Wearable Injectors
10.3 Manufacturing Process Analysis of Wearable Injectors
10.4 Industry Chain Structure of Wearable Injectors
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Wearable Injectors Distributors
11.3 Wearable Injectors Customer
12 World Forecast Review for Wearable Injectors by Geographic Region
12.1 Global Wearable Injectors Market Size Forecast by Region
12.1.1 Global Wearable Injectors Forecast by Region (2024-2029)
12.1.2 Global Wearable Injectors Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Wearable Injectors Forecast by Type
12.7 Global Wearable Injectors Forecast by Application
13 Key Players Analysis
13.1 Becton
13.1.1 Becton Company Information
13.1.2 Becton Wearable Injectors Product Portfolios and Specifications
13.1.3 Becton Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Becton Main Business Overview
13.1.5 Becton Latest Developments
13.2 Dickinson and Company
13.2.1 Dickinson and Company Company Information
13.2.2 Dickinson and Company Wearable Injectors Product Portfolios and Specifications
13.2.3 Dickinson and Company Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Dickinson and Company Main Business Overview
13.2.5 Dickinson and Company Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Wearable Injectors Product Portfolios and Specifications
13.3.3 Medtronic Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Wearable Injectors Product Portfolios and Specifications
13.4.3 Johnson & Johnson Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Insulet Corporation
13.5.1 Insulet Corporation Company Information
13.5.2 Insulet Corporation Wearable Injectors Product Portfolios and Specifications
13.5.3 Insulet Corporation Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Insulet Corporation Main Business Overview
13.5.5 Insulet Corporation Latest Developments
13.6 Unilife Corporation
13.6.1 Unilife Corporation Company Information
13.6.2 Unilife Corporation Wearable Injectors Product Portfolios and Specifications
13.6.3 Unilife Corporation Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Unilife Corporation Main Business Overview
13.6.5 Unilife Corporation Latest Developments
13.7 Enable Injections
13.7.1 Enable Injections Company Information
13.7.2 Enable Injections Wearable Injectors Product Portfolios and Specifications
13.7.3 Enable Injections Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Enable Injections Main Business Overview
13.7.5 Enable Injections Latest Developments
13.8 SteadyMed
13.8.1 SteadyMed Company Information
13.8.2 SteadyMed Wearable Injectors Product Portfolios and Specifications
13.8.3 SteadyMed Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 SteadyMed Main Business Overview
13.8.5 SteadyMed Latest Developments
13.9 Ypsomed Group
13.9.1 Ypsomed Group Company Information
13.9.2 Ypsomed Group Wearable Injectors Product Portfolios and Specifications
13.9.3 Ypsomed Group Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ypsomed Group Main Business Overview
13.9.5 Ypsomed Group Latest Developments
13.10 West Pharmaceutical Services
13.10.1 West Pharmaceutical Services Company Information
13.10.2 West Pharmaceutical Services Wearable Injectors Product Portfolios and Specifications
13.10.3 West Pharmaceutical Services Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 West Pharmaceutical Services Main Business Overview
13.10.5 West Pharmaceutical Services Latest Developments
13.11 Unilife
13.11.1 Unilife Company Information
13.11.2 Unilife Wearable Injectors Product Portfolios and Specifications
13.11.3 Unilife Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Unilife Main Business Overview
13.11.5 Unilife Latest Developments
13.12 CeQur
13.12.1 CeQur Company Information
13.12.2 CeQur Wearable Injectors Product Portfolios and Specifications
13.12.3 CeQur Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 CeQur Main Business Overview
13.12.5 CeQur Latest Developments
13.13 Sensile Medical
13.13.1 Sensile Medical Company Information
13.13.2 Sensile Medical Wearable Injectors Product Portfolios and Specifications
13.13.3 Sensile Medical Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sensile Medical Main Business Overview
13.13.5 Sensile Medical Latest Developments
13.14 BD Medical
13.14.1 BD Medical Company Information
13.14.2 BD Medical Wearable Injectors Product Portfolios and Specifications
13.14.3 BD Medical Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 BD Medical Main Business Overview
13.14.5 BD Medical Latest Developments
13.15 Roche
13.15.1 Roche Company Information
13.15.2 Roche Wearable Injectors Product Portfolios and Specifications
13.15.3 Roche Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Roche Main Business Overview
13.15.5 Roche Latest Developments
13.16 ScPharmaceuticals
13.16.1 ScPharmaceuticals Company Information
13.16.2 ScPharmaceuticals Wearable Injectors Product Portfolios and Specifications
13.16.3 ScPharmaceuticals Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 ScPharmaceuticals Main Business Overview
13.16.5 ScPharmaceuticals Latest Developments
13.17 SteadyMed
13.17.1 SteadyMed Company Information
13.17.2 SteadyMed Wearable Injectors Product Portfolios and Specifications
13.17.3 SteadyMed Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 SteadyMed Main Business Overview
13.17.5 SteadyMed Latest Developments
13.18 J & J
13.18.1 J & J Company Information
13.18.2 J & J Wearable Injectors Product Portfolios and Specifications
13.18.3 J & J Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 J & J Main Business Overview
13.18.5 J & J Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Wearable Injectors Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Wearable Injectors Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Electronical Injectors
Table 4. Major Players of Mechanical Injectors
Table 5. Major Players of Others
Table 6. Global Wearable Injectors Sales by Type (2018-2023) & (K Units)
Table 7. Global Wearable Injectors Sales Market Share by Type (2018-2023)
Table 8. Global Wearable Injectors Revenue by Type (2018-2023) & ($ million)
Table 9. Global Wearable Injectors Revenue Market Share by Type (2018-2023)
Table 10. Global Wearable Injectors Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Wearable Injectors Sales by Application (2018-2023) & (K Units)
Table 12. Global Wearable Injectors Sales Market Share by Application (2018-2023)
Table 13. Global Wearable Injectors Revenue by Application (2018-2023)
Table 14. Global Wearable Injectors Revenue Market Share by Application (2018-2023)
Table 15. Global Wearable Injectors Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Wearable Injectors Sales by Company (2018-2023) & (K Units)
Table 17. Global Wearable Injectors Sales Market Share by Company (2018-2023)
Table 18. Global Wearable Injectors Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Wearable Injectors Revenue Market Share by Company (2018-2023)
Table 20. Global Wearable Injectors Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Wearable Injectors Producing Area Distribution and Sales Area
Table 22. Players Wearable Injectors Products Offered
Table 23. Wearable Injectors Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Wearable Injectors Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Wearable Injectors Sales Market Share Geographic Region (2018-2023)
Table 28. Global Wearable Injectors Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Wearable Injectors Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Wearable Injectors Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Wearable Injectors Sales Market Share by Country/Region (2018-2023)
Table 32. Global Wearable Injectors Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Wearable Injectors Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Wearable Injectors Sales by Country (2018-2023) & (K Units)
Table 35. Americas Wearable Injectors Sales Market Share by Country (2018-2023)
Table 36. Americas Wearable Injectors Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Wearable Injectors Revenue Market Share by Country (2018-2023)
Table 38. Americas Wearable Injectors Sales by Type (2018-2023) & (K Units)
Table 39. Americas Wearable Injectors Sales by Application (2018-2023) & (K Units)
Table 40. APAC Wearable Injectors Sales by Region (2018-2023) & (K Units)
Table 41. APAC Wearable Injectors Sales Market Share by Region (2018-2023)
Table 42. APAC Wearable Injectors Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Wearable Injectors Revenue Market Share by Region (2018-2023)
Table 44. APAC Wearable Injectors Sales by Type (2018-2023) & (K Units)
Table 45. APAC Wearable Injectors Sales by Application (2018-2023) & (K Units)
Table 46. Europe Wearable Injectors Sales by Country (2018-2023) & (K Units)
Table 47. Europe Wearable Injectors Sales Market Share by Country (2018-2023)
Table 48. Europe Wearable Injectors Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Wearable Injectors Revenue Market Share by Country (2018-2023)
Table 50. Europe Wearable Injectors Sales by Type (2018-2023) & (K Units)
Table 51. Europe Wearable Injectors Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Wearable Injectors Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Wearable Injectors Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Wearable Injectors Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Wearable Injectors Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Wearable Injectors Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Wearable Injectors Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Wearable Injectors
Table 59. Key Market Challenges & Risks of Wearable Injectors
Table 60. Key Industry Trends of Wearable Injectors
Table 61. Wearable Injectors Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Wearable Injectors Distributors List
Table 64. Wearable Injectors Customer List
Table 65. Global Wearable Injectors Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Wearable Injectors Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Wearable Injectors Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Wearable Injectors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Wearable Injectors Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Wearable Injectors Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Wearable Injectors Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Wearable Injectors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Wearable Injectors Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Wearable Injectors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Wearable Injectors Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Wearable Injectors Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Wearable Injectors Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Wearable Injectors Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Becton Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 80. Becton Wearable Injectors Product Portfolios and Specifications
Table 81. Becton Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Becton Main Business
Table 83. Becton Latest Developments
Table 84. Dickinson and Company Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 85. Dickinson and Company Wearable Injectors Product Portfolios and Specifications
Table 86. Dickinson and Company Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Dickinson and Company Main Business
Table 88. Dickinson and Company Latest Developments
Table 89. Medtronic Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 90. Medtronic Wearable Injectors Product Portfolios and Specifications
Table 91. Medtronic Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Medtronic Main Business
Table 93. Medtronic Latest Developments
Table 94. Johnson & Johnson Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 95. Johnson & Johnson Wearable Injectors Product Portfolios and Specifications
Table 96. Johnson & Johnson Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Johnson & Johnson Main Business
Table 98. Johnson & Johnson Latest Developments
Table 99. Insulet Corporation Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 100. Insulet Corporation Wearable Injectors Product Portfolios and Specifications
Table 101. Insulet Corporation Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Insulet Corporation Main Business
Table 103. Insulet Corporation Latest Developments
Table 104. Unilife Corporation Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 105. Unilife Corporation Wearable Injectors Product Portfolios and Specifications
Table 106. Unilife Corporation Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Unilife Corporation Main Business
Table 108. Unilife Corporation Latest Developments
Table 109. Enable Injections Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 110. Enable Injections Wearable Injectors Product Portfolios and Specifications
Table 111. Enable Injections Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Enable Injections Main Business
Table 113. Enable Injections Latest Developments
Table 114. SteadyMed Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 115. SteadyMed Wearable Injectors Product Portfolios and Specifications
Table 116. SteadyMed Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. SteadyMed Main Business
Table 118. SteadyMed Latest Developments
Table 119. Ypsomed Group Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 120. Ypsomed Group Wearable Injectors Product Portfolios and Specifications
Table 121. Ypsomed Group Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Ypsomed Group Main Business
Table 123. Ypsomed Group Latest Developments
Table 124. West Pharmaceutical Services Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 125. West Pharmaceutical Services Wearable Injectors Product Portfolios and Specifications
Table 126. West Pharmaceutical Services Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. West Pharmaceutical Services Main Business
Table 128. West Pharmaceutical Services Latest Developments
Table 129. Unilife Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 130. Unilife Wearable Injectors Product Portfolios and Specifications
Table 131. Unilife Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Unilife Main Business
Table 133. Unilife Latest Developments
Table 134. CeQur Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 135. CeQur Wearable Injectors Product Portfolios and Specifications
Table 136. CeQur Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. CeQur Main Business
Table 138. CeQur Latest Developments
Table 139. Sensile Medical Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 140. Sensile Medical Wearable Injectors Product Portfolios and Specifications
Table 141. Sensile Medical Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 142. Sensile Medical Main Business
Table 143. Sensile Medical Latest Developments
Table 144. BD Medical Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 145. BD Medical Wearable Injectors Product Portfolios and Specifications
Table 146. BD Medical Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 147. BD Medical Main Business
Table 148. BD Medical Latest Developments
Table 149. Roche Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 150. Roche Wearable Injectors Product Portfolios and Specifications
Table 151. Roche Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 152. Roche Main Business
Table 153. Roche Latest Developments
Table 154. ScPharmaceuticals Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 155. ScPharmaceuticals Wearable Injectors Product Portfolios and Specifications
Table 156. ScPharmaceuticals Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 157. ScPharmaceuticals Main Business
Table 158. ScPharmaceuticals Latest Developments
Table 159. SteadyMed Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 160. SteadyMed Wearable Injectors Product Portfolios and Specifications
Table 161. SteadyMed Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 162. SteadyMed Main Business
Table 163. SteadyMed Latest Developments
Table 164. J & J Basic Information, Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 165. J & J Wearable Injectors Product Portfolios and Specifications
Table 166. J & J Wearable Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 167. J & J Main Business
Table 168. J & J Latest Developments
List of Figures
Figure 1. Picture of Wearable Injectors
Figure 2. Wearable Injectors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Wearable Injectors Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Wearable Injectors Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Wearable Injectors Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Electronical Injectors
Figure 10. Product Picture of Mechanical Injectors
Figure 11. Product Picture of Others
Figure 12. Global Wearable Injectors Sales Market Share by Type in 2022
Figure 13. Global Wearable Injectors Revenue Market Share by Type (2018-2023)
Figure 14. Wearable Injectors Consumed in Cancer
Figure 15. Global Wearable Injectors Market: Cancer (2018-2023) & (K Units)
Figure 16. Wearable Injectors Consumed in Infectious Disease
Figure 17. Global Wearable Injectors Market: Infectious Disease (2018-2023) & (K Units)
Figure 18. Wearable Injectors Consumed in Autoimmune Disorder
Figure 19. Global Wearable Injectors Market: Autoimmune Disorder (2018-2023) & (K Units)
Figure 20. Wearable Injectors Consumed in Cardiovascular Disease
Figure 21. Global Wearable Injectors Market: Cardiovascular Disease (2018-2023) & (K Units)
Figure 22. Wearable Injectors Consumed in Blood Disorder
Figure 23. Global Wearable Injectors Market: Blood Disorder (2018-2023) & (K Units)
Figure 24. Wearable Injectors Consumed in Others
Figure 25. Global Wearable Injectors Market: Others (2018-2023) & (K Units)
Figure 26. Global Wearable Injectors Sales Market Share by Application (2022)
Figure 27. Global Wearable Injectors Revenue Market Share by Application in 2022
Figure 28. Wearable Injectors Sales Market by Company in 2022 (K Units)
Figure 29. Global Wearable Injectors Sales Market Share by Company in 2022
Figure 30. Wearable Injectors Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Wearable Injectors Revenue Market Share by Company in 2022
Figure 32. Global Wearable Injectors Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Wearable Injectors Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Wearable Injectors Sales 2018-2023 (K Units)
Figure 35. Americas Wearable Injectors Revenue 2018-2023 ($ Millions)
Figure 36. APAC Wearable Injectors Sales 2018-2023 (K Units)
Figure 37. APAC Wearable Injectors Revenue 2018-2023 ($ Millions)
Figure 38. Europe Wearable Injectors Sales 2018-2023 (K Units)
Figure 39. Europe Wearable Injectors Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Wearable Injectors Sales 2018-2023 (K Units)
Figure 41. Middle East & Africa Wearable Injectors Revenue 2018-2023 ($ Millions)
Figure 42. Americas Wearable Injectors Sales Market Share by Country in 2022
Figure 43. Americas Wearable Injectors Revenue Market Share by Country in 2022
Figure 44. Americas Wearable Injectors Sales Market Share by Type (2018-2023)
Figure 45. Americas Wearable Injectors Sales Market Share by Application (2018-2023)
Figure 46. United States Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Wearable Injectors Sales Market Share by Region in 2022
Figure 51. APAC Wearable Injectors Revenue Market Share by Regions in 2022
Figure 52. APAC Wearable Injectors Sales Market Share by Type (2018-2023)
Figure 53. APAC Wearable Injectors Sales Market Share by Application (2018-2023)
Figure 54. China Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Wearable Injectors Sales Market Share by Country in 2022
Figure 62. Europe Wearable Injectors Revenue Market Share by Country in 2022
Figure 63. Europe Wearable Injectors Sales Market Share by Type (2018-2023)
Figure 64. Europe Wearable Injectors Sales Market Share by Application (2018-2023)
Figure 65. Germany Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Wearable Injectors Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Wearable Injectors Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Wearable Injectors Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa Wearable Injectors Sales Market Share by Application (2018-2023)
Figure 74. Egypt Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Wearable Injectors in 2022
Figure 80. Manufacturing Process Analysis of Wearable Injectors
Figure 81. Industry Chain Structure of Wearable Injectors
Figure 82. Channels of Distribution
Figure 83. Global Wearable Injectors Sales Market Forecast by Region (2024-2029)
Figure 84. Global Wearable Injectors Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Wearable Injectors Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global Wearable Injectors Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global Wearable Injectors Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Wearable Injectors Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ウェアラブルインジェクターのグローバル市場予測2023-2029(Global Wearable Injectors Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆